Alzheimer’s Disease as Proteolytic Disorders: Anabolism and Catabolism of β-Amyloid
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Neurobiology of Aging
- Vol. 19 (1) , S69-S75
- https://doi.org/10.1016/s0197-4580(98)00033-5
Abstract
No abstract availableKeywords
Funding Information
- Chugai Pharmaceutical
- Ministry of Education, Culture, Sports, Science and Technology
- Naito Foundation
- Uehara Memorial Foundation
This publication has 25 references indexed in Scilit:
- Reduction of Plasma Glutamyl Aminopeptidase Activity in Sporadic Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996
- Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brainNeuroscience Letters, 1996
- Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ42(43)Annals of Neurology, 1996
- Amino-terminal Deletions Enhance Aggregation of β-Amyloid Peptides in VitroJournal of Biological Chemistry, 1995
- Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)Neuron, 1994
- Down's Syndrome: Up‐Regulation of β‐Amyloid Protein Precursor and τ mRNAs and Their Defective CoordinationJournal of Neurochemistry, 1994
- Daily Rhythm of Aspartate Aminopeptidase Activity in the Retina, Pineal Gland and Occipital Cortex of the RatNeuroendocrinology, 1992
- The Site of the Earliest Lesions of Alzheimer's DiseaseNew England Journal of Medicine, 1988